DuPont de Nemours, Inc. Operating Cash Flow decreased by 53.3% to $232.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 201.3%, from $77.00M to $232.00M. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase indicates strong operational efficiency and cash generation, while a decrease may signal operational challenges or issues with working capital management.
This metric represents the total cash generated or consumed by a company's core business operations during a specific pe...
Standard across all industries; peers in the medical device and diagnostics sector typically maintain high conversion ratios of net income to operating cash flow.
net_cash_from_operating| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $440.00M | $842.00M | $621.00M | $209.00M | $86.00M | $419.00M | $343.00M | $462.00M | $740.00M | $493.00M | $527.00M | $497.00M | $77.00M | $686.00M | $497.00M | $232.00M |
| QoQ Change | — | +91.4% | -26.2% | -66.3% | -58.9% | +387.2% | -18.1% | +34.7% | +60.2% | -33.4% | +6.9% | -5.7% | -84.5% | +790.9% | -27.6% | -53.3% |
| YoY Change | — | — | — | — | -80.5% | -50.2% | +64.1% | +437.2% | +76.6% | +43.7% | +14.1% | -32.8% | -84.4% | +30.2% | +0.0% | +201.3% |